Medical News

RSS

SQI Diagnostics' SQiDworks automated platform and IgXPLEX RA assay receive FDA marketing clearance

SQI Diagnostics Inc., a medical systems automation company focused on evolving laboratory-based biomarker testing, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's automated SQiDworks(TM) Diagnostics Platform and its multiplexed IgXPLEX(TM) rheumatoid arthritis (RA) assay for marketing in the United States.

2 Nov 2009

MDS sells its Central Labs operations to Czura Thornton

MDS Inc., a leading provider of products and services to the global life sciences markets, today announced that it has completed the divestiture of its Central Labs operations to Czura Thornton, a private investment group based in Jersey, Channel Islands.

From Danaher 2 Nov 2009

FDA issues a Complete Response Letter for GTx' toremifene NDA

GTx, Inc. today announced that it has received a Complete Response Letter issued by the United States Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for toremifene 80 mg to reduce fractures in men with prostate cancer receiving androgen deprivation therapy (ADT).

2 Nov 2009

ZirMed forges alliance with Raintree Systems to jointly market their combined solutions

ZirMed®, a national provider of revenue cycle management services for healthcare practices, and leading integrated healthcare technology company Raintree Systems Inc. today announced a working partnership to jointly market their combined solutions to current and prospective customers. As a result of the partnership, ZirMed's flagship revenue cycle management platform will be integrated with Raintree's practice management and Electronic Medical Records (EMR) products, giving users state-of-the-art technology with which to better manage their daily operations.

2 Nov 2009

Juvaris BioTherapeutics commences enrollment in its JVRS-100 influenza vaccine adjuvant study

Juvaris BioTherapeutics, Inc., a biotechnology company developing adjuvanted vaccines for infectious diseases, today announced that it has begun enrolling patients in a Phase 2 clinical trial of its lead compound, JVRS-100, as an adjuvant for seasonal influenza vaccines in the elderly population.

2 Nov 2009

Artificial Medical Intelligence releases enhanced EMscribe CAC software

Artificial Medical Intelligence (AMI) today announced its newly enhanced EMscribe™ Computer Assisted Coding (CAC) software, version 4.0.

2 Nov 2009

Sunesis Pharmaceuticals raises $5.0 million through private placement

Sunesis Pharmaceuticals, Inc. today announced the closing of a private placement of $5.0 million of units consisting of convertible preferred stock and common stock warrants on October 30, 2009. This closing constitutes the second tranche of the private placement of up to $43.5 million of Sunesis' securities announced in April 2009.

2 Nov 2009

Valeant Pharmaceuticals announces financial results for the third quarter of 2009

Valeant Pharmaceuticals International today announced third quarter financial results for 2009.

2 Nov 2009

PDI selects Veeva System’s CRM suite of multi-tenant SaaS applications

PDI, Inc., a leading provider of sales and marketing support to U.S. pharmaceutical companies, selected Veeva System’s VBioPharma CRM Primary Care and Special Care Editions, VMobile, and VInsights – all part of the Veeva CRM suite of multi-tenant SaaS applications. This marks PDI’s continued commitment to the technology advances in the world of cloud computing where business spending on SaaS/Cloud applications is expected to rise 22% this year to $9.6 billion, according to Gartner.

2 Nov 2009

Court upholds AGA Medical’s patent, grants injunction against Occlutech's Figulla Flex occluders

AGA Medical Holdings, Inc. today announced that the German Regional Court in Düsseldorf, Germany has granted a preliminary injunction against the manufacture, possession and sale of the Figulla® Flex occluders manufactured by Occlutech GmbH in Jena, Germany.

2 Nov 2009

"Helmets for Hope" campaign launched to raise epilepsy disorder awareness

November is Epilepsy Awareness Month. The Lennox Gastaut Syndrome Foundation (LGSF) and the American Epilepsy Outreach Foundation (AEOF) has joined with Eisai Pharmaceuticals and Lundbeck Pharmaceuticals to co-host the 1st Annual Helmets for Hope(TM) Campaign.

2 Nov 2009

Results of review by Marwood Group Advisory released by Amedisys

Amedisys, Inc., one of America's leading home health and hospice nursing companies, today released the results of a review conducted by Marwood Group Advisory, LLC (Marwood). Several months ago Amedisys engaged Marwood, one of the nation’s preeminent health care consulting firms, to provide an independent analysis of the Company’s procedures, controls, clinical infrastructure, corporate compliance processes, technology offerings and future strategies.

2 Nov 2009

VEGF from the retinal pigment epithelium to the choriocapillaris leads to degeneration of the CC, study finds

Scientists at Schepens Eye Research Institute have found that when the eye is missing a diffusible form of vascular endothelial growth factor (VEGF), i.e. one that when secreted can reach other cells at a distance, the retina shows defects similar to "dry" macular degeneration, also called geographic atrophy (GA).

2 Nov 2009

Poor managerial leadership linked with the amont of sick leave taken at workplace

Perceived poor managerial leadership increases not only the amount of sick leave taken at a workplace, but also the risk of sickness amongst employees later on in life. The longer a person has had a "poorer" manager, the higher his or her risk of for example suffering a heart attack within a ten-year period, according to a new thesis from the Swedish medical university Karolinska Institutet.

2 Nov 2009

Perrigo announces financial results for the first quarter of fiscal 2010

Perrigo Company today announced results for its first quarter ended September 26, 2009.

2 Nov 2009

Perrigo to sell its Israel Consumer Products business to Emilia Group

Perrigo Company today announced that it has signed a definitive agreement to sell its Israel Consumer Products business along with the related production assets in Israel to Emilia Group, a subsidiary of O. Feller Holdings Ltd., for 205 million New Israeli Shekels (approximately $54 million).

2 Nov 2009

Arrayit Corporation joins federal government in their efforts to help control health care costs

Arrayit Corporation is pleased to join the federal government in their efforts to help control health care costs by leveraging Arrayit's leading edge health care platform.

2 Nov 2009

Avila Therapeutics presents preclinical study data of its AVL-181 HCV protease inhibitor

Avila Therapeutics™, Inc., a biotechnology company developing novel covalent drugs that treat diseases through protein silencing, presented results of preclinical studies on its highly selective, small molecule Hepatitis C Virus (HCV) protease inhibitor, AVL-181. Avila showed that AVL-181 promoted complete viral clearance in vitro when used at clinically-relevant concentrations in combination with other HCV therapies.

2 Nov 2009

New on-line job resource center launched by NAWC

The National Alliance of Wound Care (NAWC(®)), the largest, multi-disciplinary, wound care credentialing and association organization, announced today, the launch of their wound care specialty on-line Job Resource Center in conjunction with their newly redesigned website at, www.nawccb.org.

2 Nov 2009

Alnylam Pharmaceuticals presents new data from its transthyretin-mediated amyloidosis program

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it presented new pre-clinical research findings from its transthyretin (TTR)-mediated amyloidosis (ATTR) program at the 60th Annual Meeting of the American Association for the Study of Liver Diseases (“The Liver Meeting”).

2 Nov 2009

Medical News

SQI Diagnostics' SQiDworks automated platform and IgXPLEX RA assay receive FDA marketing clearance

MDS sells its Central Labs operations to Czura Thornton

FDA issues a Complete Response Letter for GTx' toremifene NDA

ZirMed forges alliance with Raintree Systems to jointly market their combined solutions

Juvaris BioTherapeutics commences enrollment in its JVRS-100 influenza vaccine adjuvant study

Artificial Medical Intelligence releases enhanced EMscribe CAC software

Sunesis Pharmaceuticals raises $5.0 million through private placement

Valeant Pharmaceuticals announces financial results for the third quarter of 2009

PDI selects Veeva System’s CRM suite of multi-tenant SaaS applications

Court upholds AGA Medical’s patent, grants injunction against Occlutech's Figulla Flex occluders

"Helmets for Hope" campaign launched to raise epilepsy disorder awareness

Results of review by Marwood Group Advisory released by Amedisys

VEGF from the retinal pigment epithelium to the choriocapillaris leads to degeneration of the CC, study finds

Poor managerial leadership linked with the amont of sick leave taken at workplace

Perrigo announces financial results for the first quarter of fiscal 2010

Perrigo to sell its Israel Consumer Products business to Emilia Group

Arrayit Corporation joins federal government in their efforts to help control health care costs

Avila Therapeutics presents preclinical study data of its AVL-181 HCV protease inhibitor

New on-line job resource center launched by NAWC

Alnylam Pharmaceuticals presents new data from its transthyretin-mediated amyloidosis program

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News